In the world of fee-for-service health care, most medical devices were sold to hospitals or other health care providers for use in the diagnosis or treatment of patients. Except in the case of durable medical equipment, health insurers rarely pay for the devices separately, so the principal aim of the medical device maker was to provide a quality product at a price point that would still allow the purchaser to make money on the procedure in which the device was used. The device maker had little need to concern itself with the other costs of the procedure, or with whether the procedure improved the patient’s quality of life. VBC’s focus on reducing cost and improving the patient’s outcome presents device makers with new challenges and new opportunities. Device makers increasingly are acquiring or creating consulting or management capabilities in order to offer customers a complete solution to the procedures in which their devices are used. This section will report on the impact of VBC on the medical device business.
Ropes & Gray regularly examines trends, developments and issues in value-based health care to provide guidance on this rapidly evolving topic.
- Impact of Value-Based Health Care on the Medical Device Industry: Three Takeaways From the Case for Transformation (September 7, 2017)
- Drug and Device Makers Suggest Anti-Kickback Safe Harbor Clarifications to Encourage Value-Based Health Care Arrangements (March 17, 2017)
- What’s Ahead for Value-Based Health Care? (February 22, 2017)
- “Early Lessons on Bundled Payment at an Academic Medical Center,” Journal of the AAOS (September 2017)
- “Hospitals call on Trump administration to end mandatory bundled pay programs,” Modern Healthcare (April 24, 2017)
- “Debate Over Mandatory Versus Voluntary Pay Bundles Resurface,” Inside Health Policy (subscription only) (April 12, 2017)
- “Unravelling Bundled Payments: A New Chapter In Reimbursement For Orthopedics,” MedTech Insight (subscription only) (April 2017)
- “CMS Launches Three New Mandatory Bundled Payment Models,” Advisory Board (December 2016)
- “CMS Finalizes Mandatory Cardiac Care Bundled Payment Model and More,”Health Care Law Today (December 2016)
- “Comprehensive Care for Joint Replacement (CJR) Final Rule Summary,” American Health Care Association (November 2016)
- “Value-Based Payment Models: Implications for Medical Device Manufacturers,” Medical Device and Diagnostic Industry (August 2016)
- “Economics Will Drive the Evolution of the Medical Device Industry,” MedTech Insight (April 2016)
- “Medical Device Innovation in the Era of the Affordable Care Act,”Rand Corporation (2016)
- “How to Succeed in Value-Based, Patient-Center Care, A Briefing for Medical Device Companies,”Oliver Wyman (September 2014)